Alnara Pharmaceuticals, Inc. Flourishes from Altus Pharmaceuticals Inc. Demise

Mass High Tech -- Alnara Pharmaceuticals Inc. stands ready to send its drug target to treat cystic fibrosis to the U.S. Food and Drug Administration, a mere 16 months after the company raised its first venture capital round of $20 million.